Medicure (MCUJF) Non-Current Deferred Tax Liability (2016 - 2017)
Medicure (MCUJF) recorded quarterly Non-Current Deferred Tax Liability of $478968.2 in Q4 2017, down 98.22% quarter-over-quarter from $26.9 million in Q3 2017, and down 98.33% on a YoY basis from $28.6 million in Q4 2016.
Medicure (MCUJF) Non-Current Deferred Tax Liability (2016 - 2017) Analysis & Trends
Medicure's Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $478968.2 for Q4 2017.
- In Q4 2017, Non-Current Deferred Tax Liability fell 98.33% year-over-year to $478968.2; the TTM figure through Dec 2017 stood at $478968.2 (down 98.33% YoY), while the FY2017 annual figure was $469025.3, down 98.36% from the prior year.
- Non-Current Deferred Tax Liability was $478968.2 for Q4 2017 at Medicure, down from $26.9 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $28.6 million in Q4 2016 to a low of $478968.2 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Medicure | - | - | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 478,968.19 |
| Dec 31, 2017 | 478,968.19 |
| Sep 30, 2017 | 26.86 Mn |
| Sep 30, 2017 | 26.86 Mn |
| Jun 30, 2017 | 26.25 Mn |
| Jun 30, 2017 | 26.25 Mn |
| Mar 31, 2017 | 27.06 Mn |
| Mar 31, 2017 | 27.06 Mn |
| Dec 31, 2016 | 28.60 Mn |
| Dec 31, 2016 | 28.60 Mn |